Clinical Trial Update: Sunitinib and Capecitabine for First Line Colon Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of sunitinib and capecitabine as first-line therapy for metastatic colorectal cancer; the study was terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Sunitinib (sunitinib)

Snippet

Sponsor: Georgetown University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-04-21